Product Details
Indicated In The Treatment Of Asthma As Add-On Therapy In Those 6 To 14 Year Old Patients With Mild To Moderate Persistent Asthma Who Are Inadequately Controlled On Inhaled Corticosteroids And In Whom 'As-Needed' Short-Acting Β-Agonists Provide Inadequate Clinical Control Of Asthma.
